Scarllet Remedies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 25-12-2024
- Paid Up Capital ₹ 0.10 M
as on 25-12-2024
- Company Age 9 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.65 Cr
as on 25-12-2024
- Revenue %
(FY 2020)
- Profit 101.29%
(FY 2020)
- Ebitda 101.53%
(FY 2020)
- Net Worth 1.02%
(FY 2020)
- Total Assets 5732.20%
(FY 2020)
About Scarllet Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.65 Cr.
Sarita Taur, Pankaj Jaiswal, Mamta Gupta, and One other member serve as directors at the Company.
- CIN/LLPIN
U74120MP2015PTC034574
- Company No.
034574
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Aug 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Nimar, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Scarllet Remedies Private Limited offer?
Scarllet Remedies Private Limited offers a wide range of products and services, including Antipyretic Medication, Paracetamol Suspension, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Cholesterol Medicine, Tricholine Citrate Syrup, Antacid Drugs, Rabeprazole Domperidone Capsule.
Who are the key members and board of directors at Scarllet Remedies?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sarita Taur  | Additional Director | 27-Jul-2021 | Current |
| Pankaj Jaiswal | Additional Director | 27-Jul-2021 | Current |
| Mamta Gupta | Additional Director | 27-Jul-2021 | Current |
| Rahul Tour | Director | 14-Aug-2015 | Current |
Financial Performance of Scarllet Remedies.
Scarllet Remedies Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 101.29% increase in profit. The company's net worth moved up by a moderate rise of 1.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Scarllet Remedies?
In 2020, Scarllet Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Mar 2022 | ₹2.65 Cr | Open |
How Many Employees Work at Scarllet Remedies?
Unlock and access historical data on people associated with Scarllet Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Scarllet Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scarllet Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
